Cai Yu Chun, Wu Fen, Hu Wei, Chen Jiaxu, Chen Shao Hong, Xu Bin, Lu Yan, Ai Lin, Yang Chun Li, Zhao Shimin
School of Life Sciences, Fudan University, Shanghai, 200433, China; National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, China; Laboratory of Parasite and Vector Biology, Ministry of Public Health, China; WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China.
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, China; Laboratory of Parasite and Vector Biology, Ministry of Public Health, China; WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Ministry of Science and Technology, Shanghai 200025, China.
Acta Trop. 2018 Sep;185:371-379. doi: 10.1016/j.actatropica.2018.03.020. Epub 2018 Mar 17.
Babesiosis has become a new global threat impacting human health, and most human babesiosis cases are caused by Babesia microti. Until now few antigens of B. microti have been described which can be used for the diagnosis of human babesiosis. In the present study, we report on the bioinformatic analysis, cloning and expression of the sequence encoding the B. microti seroreactive antigen 5-1-1 to investigate its potential incorporation in serologic diagnostic tools for babesiosis. Bioinformatic analysis and recombinant gene expression were performed to molecularly characterize seroreactive antigen 5-1-1. Enhanced chemiluminescence (ECL)-Western blot methods were used to detect specific antibodies in infected mice. Immunofluorescence antibody assays (IFA) were performed to detect the localization of BmSA5-1-1 in B. microti parasites. ELISA and immunochromatographic (ICT) tests were developed using recombinant BmSA5-1-1 to evaluate its potential use in rapid detection methods for B. microti antibodies and for the diagnosis of babesiosis. A recombinant expression plasmid was constructed by inserting the target gene fragment in the pET28a vector after double digestion with BamHI and XhoI restriction enzymes. The recombinant BmSA5-1-1 protein was expressed in Escherichia coli (rBmSA5-1-1) and purified by means of Ni-nitrilotriacetic acid (NTA) agarose columns. Polyclonal antibodies were generated against rBmSA5-1-1. Based on indirect immunofluorescence assay results, BmSA5-1-1 appeared to localize on the surface of B. microti. ELISA tests using the rBmSA5-1-1 antigen detected specific antibodies from infected mice as early as 4 days post-infection. Our results indicate that the two methods we developed can detect specific antibodies in mice at different stages of infection with sensitivities of 100% (rBmSA5-1-1 ELISA) and 90% (ICT). The specificity of the two methods was 100%. Sera of patients suffering from other closely related parasitic diseases, such as malaria and toxoplasmosis, produced negative results. In conclusion, seroreactive antigen 5-1-1, a member of the BMN1 protein family, is expressed on the outer surface of B. microti and is a promising candidate antigen for the early diagnosis of babesiosis. rBmSA5-1-1 ELISA and ICT methods show good potential for detecting specific antibodies in mice at different stages of infection.
巴贝斯虫病已成为影响人类健康的新的全球威胁,大多数人类巴贝斯虫病病例由微小巴贝斯虫引起。到目前为止,已描述的可用于诊断人类巴贝斯虫病的微小巴贝斯虫抗原很少。在本研究中,我们报告了微小巴贝斯虫血清反应性抗原5-1-1编码序列的生物信息学分析、克隆和表达,以研究其在巴贝斯虫病血清学诊断工具中的潜在应用。进行生物信息学分析和重组基因表达以对血清反应性抗原5-1-1进行分子特征描述。采用增强化学发光(ECL)-蛋白质印迹法检测感染小鼠体内的特异性抗体。进行免疫荧光抗体试验(IFA)以检测微小巴贝斯虫表面抗原5-1-1(BmSA5-1-1)在微小巴贝斯虫寄生虫中的定位。使用重组BmSA5-1-1开发酶联免疫吸附测定(ELISA)和免疫层析(ICT)试验,以评估其在微小巴贝斯虫抗体快速检测方法及巴贝斯虫病诊断中的潜在应用。通过用BamHI和XhoI限制性内切酶双酶切后将目标基因片段插入pET28a载体构建重组表达质粒。重组BmSA5-1-1蛋白在大肠杆菌中表达(rBmSA5-1-1),并通过镍-亚氨基三乙酸(NTA)琼脂糖柱纯化。制备了针对rBmSA5-1-1的多克隆抗体。基于间接免疫荧光试验结果,BmSA5-1-1似乎定位于微小巴贝斯虫表面。使用rBmSA5-1-1抗原的ELISA试验最早在感染后4天就能检测到感染小鼠体内的特异性抗体。我们的结果表明,我们开发的两种方法能够在感染的不同阶段检测小鼠体内的特异性抗体,灵敏度分别为100%(rBmSA5-1-1 ELISA)和90%(ICT)。这两种方法的特异性均为100%。患有其他密切相关寄生虫病(如疟疾和弓形虫病)的患者血清检测结果为阴性。总之,血清反应性抗原5-1-1是BMN1蛋白家族成员,在微小巴贝斯虫表面表达,是巴贝斯虫病早期诊断的一个有前景的候选抗原。rBmSA5-1-1 ELISA和ICT方法在检测感染不同阶段小鼠体内特异性抗体方面显示出良好潜力。